Drug: Cresemba (isavuconazonium sulfate)

Manufacturer: Astellas

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of invasive aspergillosis and invasive mucormycosis in adults and pediatric patients 6 years of age and older who weigh at least 16 kilograms

Disease: invasive aspergillosis, mucormycosis

Therapeutic Area: Infectious disease

Enrollment Form Link: astellaspharmasupportsolutions.com/cresemba/forms

Phone Number: 1-800-477-6472

Fax Number: 1-866-317-6235

Product Website: cresemba.com